THE CHARACTERIZATION OF THE PHARMACOKINETIC PROFILE OF ANTI-TUMOR B (ATB) IN ORAL CANCER PATIENTS

被引：0
|
作者：
Chen, Jie [1 ]
Zheng, Zicong [1 ]
Srinual, Songpol [1 ]
Sun, Rongjin [1 ]
Yin, Taijun [1 ]
Saponjac, Vesna Tumbas [1 ]
Singh, Rashim [1 ]
You, Ming [2 ]
Wong, Stuart [1 ,3 ]
Hu, Ming
机构：
[1] Univ Houston, Houston, TX USA
[2] Houston Methodist, Houston, TX USA
[3] Med Coll Wisconsin, Madison, WI USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P30
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
    Wang, Si-si
    Liu, Wei
    Ly, Dalam
    Xu, Hao
    Qu, Limei
    Zhang, Li
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (01) : 6 - 18
  • [32] The role of B-1 cells in cancer progression and anti-tumor immunity
    Rodriguez-Zhurbenko, Nely
    Hernandez, Ana M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Differentiation and cloning for anti-tumor immunity of intratumoral B cells in gastric cancer
    Yamakoshi, Yoshihito
    Tanaka, Hiroaki
    Sakimura, Chie
    Nishimura, Junya
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Muguruma, Kazuya
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER SCIENCE, 2018, 109 : 950 - 950
  • [34] Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration
    Zhao, Mengfan
    Jing, Ziwei
    Zhou, Lin
    Zhao, Hongyu
    Du, Qiuzheng
    Sun, Zhi
    CURRENT DRUG METABOLISM, 2020, 21 (14) : 1117 - 1126
  • [35] PHARMACOKINETIC AND ANTI-TUMOR STUDIES WITH THE RADIOSENSITIZER MISONIDAZOLE IN DOGS WITH SPONTANEOUS FIBROSARCOMAS
    CREASEY, WA
    THRALL, DE
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1982, 43 (06) : 1015 - 1018
  • [36] Pharmacokinetic evaluation of a novel anti-tumor agent, PM01120
    Yin, J.
    Aviles, R.
    Guillen, M. J.
    Ly, C.
    Lee, W.
    Soto, A.
    Munt, S.
    Cuevas, C.
    Faircloth, G.
    EJC SUPPLEMENTS, 2006, 4 (12): : 156 - 156
  • [37] Delivery of G3139 using releasable PEG-linkers: Impact on pharmacokinetic profile and anti-tumor efficacy
    Zhao, Hong
    Peng, Ping
    Longley, Clifford
    Zhang, Yue
    Borowski, Virna
    Mehlig, Mary
    Reddy, Prasanna
    Xia, Jing
    Borchard, Gerrit
    Lipman, Jack
    Benimetskaya, Luba
    Stein, C. A.
    JOURNAL OF CONTROLLED RELEASE, 2007, 119 (02) : 143 - 152
  • [38] A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
    Manijeh Goldberg
    Aaron Manzi
    Amritpreet Birdi
    Brandon Laporte
    Peter Conway
    Stefanie Cantin
    Vasudha Mishra
    Alka Singh
    Alexander T. Pearson
    Eric R. Goldberg
    Sam Goldberger
    Benjamin Flaum
    Rifat Hasina
    Nyall R. London
    Gary L. Gallia
    Chetan Bettegowda
    Simon Young
    Vlad Sandulache
    James Melville
    Jonathan Shum
    Sonya E. O’Neill
    Erkin Aydin
    Alex Zhavoronkov
    Anxo Vidal
    Atenea Soto
    Maria Jose Alonso
    Ari J. Rosenberg
    Mark W. Lingen
    Anil D’Cruz
    Nishant Agrawal
    Evgeny Izumchenko
    Nature Communications, 13
  • [39] Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing mice
    Lv, S
    Zhang, JP
    Wu, J
    Zheng, XJ
    Chu, YW
    Xiong, SD
    IMMUNOLOGY LETTERS, 2005, 99 (02) : 217 - 227
  • [40] B cell anti-tumor immune responses in renal cell carcinoma patients
    Barak, Liat
    Bercovich, Shayel
    Levy-Barda, Adva
    Sarusi-Portuguez, Avital
    Blecher, Ronnie
    Naamneh, Rabab
    Imkeller, Katharina
    Golan, Shay
    Shulman, Ziv
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1584 - 1584
12345